The wet weight of the stomach, small intestine, caecum, and colon were significantly reduced (p<0O001) in intravenously fed rats compared with orally fed controls. Human epidermal growth factor (urogastrone) reversed this atrophy. Detailed analysis of the small intestine showed a similar effect on intestinal crypt cell population, mitoses per crypt, and protein content. Brush border y glutamyltransferase and a glucosidase activities were reduced by up to 50% throughout the small intestine of the animals fed intravenously. The specific activities (mU/mg protein) were unchanged, as a concomitant decrease in the tissue weight and protein content also occurred. Intestinal brush border enzyme activities in the rats treated with urogastrone-epidermal growth factor were restored to those seen in the orally fed rats except for a glucosidase activity in the proximal gut. In addition, the specific activity of y glutamyltransferase was highly significantly increased (p<001) in all regions of the small intestine. Thus, although urogastrone administration prevents the decrease in brush border enzyme activity seen after the removal of luminal nutrition, the response seems to differ depending on the intestinal location, with the specific activities of some enzymes being higher than those seen in orally fed rats. Urogastrone-epidermal growth factor can thus significantly increase the functional ability of the intestine in addition to its trophic effects. While many aspects of the molecular biology of epidermal growth factor are now well understood,' its role in vivo is still uncertain. It stimulates the proliferation and maturation of the neonatal intestine,2A the functional maturity of the preweaning intestine,' and the maturation of brush border enzymes in the neonate.67 Recent studies have also shown human epidermal growth factor, or urogastrone, to be a potent stimulator of intestinal epithelial cell proliferation in adult animals" and in humans."' This proliferative effect is dependent on the induction of polyamine synthesis." The effect of epidermal growth factor on intestinal function, however, remains unclear. The aim of this study was to (i) investigate the effects of urogastrone-epidermal growth factor on the activity of two intestinal brush border enzymes in adult rats and (ii) to determine whether the changes in enzyme activities were related to variations in proliferative activity.
Effects of urogastrone-epidermal growth factor on intestinal brush border enzymes and mitotic activity R A Goodlad, K B Raja, T J Peters, N A Wright Abstract The wet weight of the stomach, small intestine, caecum, and colon were significantly reduced (p<0O001) in intravenously fed rats compared with orally fed controls. Human epidermal growth factor (urogastrone) reversed this atrophy. Detailed analysis of the small intestine showed a similar effect on intestinal crypt cell population, mitoses per crypt, and protein content. Brush border y glutamyltransferase and a glucosidase activities were reduced by up to 50% throughout the small intestine of the animals fed intravenously. The specific activities (mU/mg protein) were unchanged, as a concomitant decrease in the tissue weight and protein content also occurred. Intestinal brush border enzyme activities in the rats treated with urogastrone-epidermal growth factor were restored to those seen in the orally fed rats except for a glucosidase activity in the proximal gut. In addition, the specific activity of y glutamyltransferase was highly significantly increased (p<001) in all regions of the small intestine. Thus, although urogastrone administration prevents the decrease in brush border enzyme activity seen after the removal of luminal nutrition, the response seems to differ depending on the intestinal location, with the specific activities of some enzymes being higher than those seen in orally fed rats. Urogastrone-epidermal growth factor can thus significantly increase the functional ability of the intestine in addition to its trophic effects. (Table) . The wet weight of the stomach, small intestine, caecum, and colon were significantly reduced (p<000l) after intravenous feeding. The reduction in intestinal weight as well as in stomach, caecum, estine and colon weight was, however, prevented by licular concomitant urogastrone-epidermal growth as cut factor administration. Due to the apparent Slides differences in body weight between the three groups, the relative weights of the stomach, caecum, and colon (expressed as a per cent of body weight) were significantly (p<O0OOl) ] heavier in the group receiving a combination of intravenous feeding and urogastrone than the orally fed group (Fig 1) . The length of the small intestine was decreased in the group fed intravenously and was little changed by urogastrone treatment. The colon was appreciably shorter after intravenous feeding but was significantly lengthened after urogastrone administration.
The crypt length (cell column count) was reduced (p<0O001) in the rats fed intravenously (Fig 2) and was restored to normal levels when urogastrone was administered. Intravenous feeding ofthe animals also resulted in over a 30% reduction in the crypt diameter, this being partially restored with urogastrone treatment (Fig 2) . Consequentially, the crypt cell population in the third group, although significantly greater than in the group fed intravenously (p<OOOl) was less than that seen in the orally fed rats (p<001 (Fig 2) .
A similar pattern was also seen in the weight of the isolated intestinal segments (Fig 3) . The protein content of the tissue samples obtained from the three regions of the gut was also significantly reduced in the group fed intravenously. The values were likewise significantly increased by the urogastrone administration, though not to the same extent as with the weights (compare Fig 3 top and bottom) . Brush border ct glucosidase and y glutamyltransferase activities (mU/cm gut) were reduced by 25-50% in all regions of the small intestine of the intravenously fed animals compared with the orally fed group (Figs 4 and 5, top). Enzyme activity was restored to the levels seen in orally fed animals after urogastrone administration, with the exception of ct glucosidase in the proximal intestine. When enzyme activities were expressed as specific activity (mU/ mg protein), no significant changes were seen in any of the three intestinal regions of the group fed intravenously compared with oral values (Figs 4 and 5, bottom) . This observation is attributable to the fact that the intestinal protein content decreased by a similar amount in all three intestinal regions during intravenous feeding (Fig 3, bottom) . Furthermore, ot glucosidase specific activities were not significantly altered after concomitant urogastrone administration. In contrast, the specific activity of y glutamyltransferase was increased in all regions after urogastrone administration compared with values in either the intravenously or the orally fed groups (Fig 4, bottom) .
Discussion
The proliferative effects of urogastroneepidermal growth factor were confirmed in the present experiment, especially when the weight increase of the orally fed group was taken into account. Although the proliferative response was evident in the small intestine, it was generally less pronounced than that in other regions of the gastrointestinal tract. This may be due to differences in the susceptibility of the organs to the effects of urogastrone. There has also been recent evidence of the colon having considerably more epidermal growth factor receptors than the small intestine. '8 Data for the caecum and stomach are not available.
Morphometric analysis of the small intestinal mucosa showed that the crypt length was significantly reduced by intravenous feeding and restored by urogastrone treatment. The crypt cell population values, however, seemed not to be fully restored in the group receiving intravenous feeding + urogastrone due to the incomplete recovery of the crypt diameter. The crypt stomach, but as the length of the gastric glands were also increased, the proliferative activity and gland cell production were in fact appreciably increased. "9 The activities of both a glucosidase and y glutamyltransferase fell greatly with intravenous feeding. The absence of a change in the specific activity with such feeding suggests that the decrease in enzyme activity is a consequence of intestinal atrophy. The activity of both enzymes was restored to normal after urogastrone treatment, with the exception of the proximal intestinal a glucosidase. The 
